- 1、本文档共7页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Mifepristone and misoprostol for termination of pregnancy efficacy of medium-term
PAGE \* MERGEFORMAT 7
Mifepristone and misoprostol for termination of pregnancy efficacy of medium-term
[Abstract] Objective Mifepristone mid-pregnancy termination patients. Methods 168 patients were randomly divided into A, B, C three groups, maternal age, maternal time, pregnancy week by the statistically non- significant differences, comparable. A group of mifepristone and misoprostol, B group received mifepristone rivanol, C were given rivanol. Results The group was not significantly different ( Pgt; 0.05, A group of labor, blood loss, adjunct residue, complications were better than B, C group (P lt;0.05, lt;0.01. Conclusion Mifepristone mid-pregnancy termination safe effective.
[Keywords:] mifepristone misoprostol trimester rivanol
September 2003 to December 2008, our department with mifepristone and misoprostol to terminate mid-pregnancy, received good effect, are as follows.
1 Subjects and methods
1.1 Observation of object choice from September 2003 to December 2008 in our department from 168 patients hospitalized patients, aged 18 to 46 years old, pregnant and a production capacity from 0 to pregnant 6 2 13 ~ 28 weeks of pregnancy, B-ultrasound consistent with gestational age . termination of pregnancy is mainly due to unplanned pregnancies, malformations, pregnancy complications, stillbirth and so on. admission of blood, urine, stool, vaginal discharge normal, PT, APTT, liver and kidney functions were normal in all patients agree that medical termination of pregnancy, and use of mifepristone and misoprostol no contraindication .168 were randomly divided into A, B, C three groups, three groups of pregnant women age, pregnancy, maternity times, weeks pregnant so difference was not statistically significant ( Pgt; 0.05, comparable.
1.2 Method A: mifepristone 50 mg, q 12 h orally, the first dose of double the total 300 mg, 2 h fasting before and after taking the first 3 days served last morning 6:00 50 mg mifepristone, 8:00 emptying th
您可能关注的文档
- Microbial sources of antibiotic JXJ-301-1 Study.doc
- Microbiological examination of project applications common mistakes.doc
- Microbiological turbidimetric assay potency of gentamicin sulfate particles.doc
- Microbiological laboratory quality control management.doc
- Microbiology and application of rapid detection methods.doc
- Microblogging - for the tourist attractions takeoff wings.doc
- Microblogging vibrant business model Zatan.doc
- Microbial transformation generated Polydatin crude extracts of resveratrol.doc
- Microblogging time interactive EQ upper.doc
- Microblogging Marketing- High up to fans.doc
- Mifepristone and misoprostol for termination from 12 to 20 weeks Pregnancy.doc
- Mifepristone and misoprostol and mid-pregnancy termination rivanol Comparison.doc
- Mifepristone and misoprostol for termination of pregnancy from 12 to 16 weeks clinical observation.doc
- Mifepristone and misoprostol for termination of pregnancy from 5 to 18 weeks compared.doc
- Mifepristone and misoprostol in early pregnancy induction of labor in the application of.doc
- Mifepristone and Misoprostol in labor induction in Lee Van Noor Effect.doc
- Mifepristone and misoprostol in the induction of labor of pregnant.doc
- Mifepristone and misoprostol in missed abortion of.doc
- Mifepristone and Misoprostol in postmenopausal women taking IUD application.doc
- Mifepristone and misoprostol for termination of 12 to 16 weeks of Pregnancy.doc
文档评论(0)